期刊文献+

脓毒症患儿血浆miR-455-5p和miR-483-5p检测的临床应用 被引量:2

Clinical Application of Plasma miR-455-5p and miR-483-5p in Children with Sepsis
下载PDF
导出
摘要 目的分析脓毒症(Sepsis)患儿血浆微小核糖核酸(micro RNA,miR)-455-5p和miR-483-5p检测及其临床价值。方法选择2019年1月~2020年12月三亚市人民医院收治的108例脓毒症患儿,根据其病情严重程度分为脓毒症非休克组(n=65)和脓毒症休克组(n=43);根据脓毒症患儿28天的生存情况,将其分为存活组(n=74)和死亡组(n=34),另选取50例健康儿童作为对照组,检测各组血浆miR-455-5p和miR-483-5p表达水平。应用受试者工作特征曲线(ROC)分析血浆miR-455-5p,miR-483-5p及降钙素原(procalcitonin,PCT)水平对脓毒症诊断及预后评估的价值。结果脓毒症休克组血浆miR-455-5p(4.06±1.35),miR-483-5p(3.40±1.13)及PCT(19.97±9.12μg/L)水平均明显高于脓毒症非休克组(1.95±0.81,1.38±0.57,5.73±2.36μg/L)和对照组(0.78±0.24,0.35±0.10,0.02±0.01μg/L),差异均有统计学意义(t=12.985~24.638,均P<0.01)。死亡组血浆miR-455-5p(4.30±1.52),miR-483-5p(3.61±1.24)及PCT(21.35±9.58)水平均明显高于存活组(1.74±0.68,1.20±0.45,4.36±1.94μg/L)和对照组,差异均有统计学意义(t=10.513~21.719,均P<0.01)。ROC曲线分析显示,miR-455-5p,miR-483-5p及PCT联合诊断脓毒症的曲线下面积(AUC)最大(0.904,95%CI:0.846~0.967),其敏感度和特异度分别为92.4%和83.7%。miR-455-5p,miR-483-5p及PCT联合预测脓毒症患儿死亡的AUC最大(0.928,95%CI:0.870~0.984),其敏感度和特异度分别为94.7%和86.5%。结论脓毒症患儿血浆miR-455-5p和miR-483-5p表达水平明显升高,联合PCT检测有助于提高儿童脓毒症的诊断及预后评估价值。 Objective To analyze the detection and clinical value of plasma miR-455-5p and miR-483-5p in children with Sepsis.Methods 108 cases children with sepsis admitted to Sanya People’s Hospital from January 2019 to December 2020 were divided into sepsis non shock group(n=65)and sepsis shock group(n=43).According to the 28 day survival of children with sepsis,they were divided into two groups:survival group(n=74)and death group(n=34).Another 50 healthy children were selected as the control group.The expression levels of plasma miR-455-5p and miR-483-5p were detected in each group.Receiver operating characteristic curve(ROC)was used to analyze the value of plasma levels of miR-455-5p,miR-483-5p and procalcitonin(PCT)for the diagnosis and prognosis of sepsis.Results The levels of plasma miR-455-5p(4.06±1.35),miR-483-5p(3.40±1.13)and PCT(19.97±9.12μg/L)in septic shock group were significantly higher than those in septic non shock group(1.95±0.81,1.38±0.57,5.73±2.36μg/L)and control group(0.78±0.24,0.35±0.10,0.02±0.01μg/L),the differences were statistically significant(t=12.985~24.638,all P<0.01).The levels of plasma miR-455-5p(4.30±1.52),miR-483-5p(3.61±1.24)and PCT(21.35±9.58μg/L)in the death group were significantly higher than those in the survival group(1.74±0.68,1.20±0.45,4.36±1.94μg/L)and control group,the differences were statistically significant(t=10.513~21.719,all P<0.01).ROC curve analysis showed that the area under the curve(AUC)of miR-455-5p,miR-483-5p and PCT in the diagnosis of sepsis was the largest(0.904,95%CI:0.846~0.967),with a sensitivity of 92.4%and a specificity of 83.7%.The AUC of miR-455-5p,miR-483-5p and PCT in predicting the death of children with sepsis was the largest(0.928,95%CI:0.870~0.984),with a sensitivity of 94.7%and a specificity of 86.5%.Conclusion The expression levels of plasma miR-455-5p and miR-483-5p in children with sepsis were significantly increased.Combined with PCT detection,it is helpful to improve the value of diagnosis and prognosis evaluation of children with sepsis.
作者 邓颖云 邱成英 吴日暖 匡晓玲 卢磊 DENG Ying-yun;QIU Cheng-ying;WU Ri-nuan;KUANG Xiao-ling;LU Lei(Department of Pediatrics,Sanya People’s Hospital,Hainan Sanya 572000,China)
出处 《现代检验医学杂志》 CAS 2022年第3期79-82,共4页 Journal of Modern Laboratory Medicine
关键词 脓毒症 儿童 微小核糖核酸-455-5p 微小核糖核酸-483-5p sepsis children miR-455-5p miR-483-5p
  • 相关文献

参考文献4

二级参考文献26

  • 1Dawei Wang,Yimei Yin,Yongming Yao.Advances in sepsis-associated liver dysfunction[J].Burns & Trauma,2014,2(3):97-105. 被引量:15
  • 2马莉,刘翠青,刘智慧,刘素哲,贾系群,李文静,胡皓夫.可溶性细胞间黏附分子-1、降钙素原在新生儿败血症诊断中的价值[J].中华儿科杂志,2004,42(9):654-658. 被引量:33
  • 3樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 4Goldstein B,Giroir B,Randolph A,et al.International pediatric sepsis consensus conference:definitions for sepsis and organ dysfunction in pediatrics[J].PediatrCrit Care Med,2005,6(1):2-8.
  • 5Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39 (2):165-228.
  • 6Dohna-Schwake C,Felderhoff-Müser U.Early recognition of septic shock in Children[J].Klin Padiatr 2013,225 (4):201-205.
  • 7Biban P,Gaffuri M,Spaggiari S,et al.Early recognition and management of septic shock in children[J].Pediatr Rep,2012,4(1):e13.
  • 8Brierley J,Carcillo JA,Choong K,et al.Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock:2007 update from the American College of Critical Care Medicine[J].Crit Care Med,2009,37(2):666-688.
  • 9Aneja R,Carcillo J.Differences between adult and pediatric septic shock[J].Minerva Anestesiol,2011,77(10):986-992.
  • 10Weil MH,Henning RJ.New concepts in the diagnosis and fluid treatment of circulatory shock.Thirteenth annual Becton,Dickinson and Company Oscar Schwidetsky Memorial Lecture[J].Anesth Analg,1979,58 (2):124-132.

共引文献411

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部